Results 191 to 200 of about 274,076 (393)

Risk of neutropenia with clopidogrel

open access: yesJournal of the American College of Cardiology, 2000
Dr. Berger et al. presented a cogent comparison of ticlopidine and clopidogrel after intracoronary artery stent placement [(1)][1]. However, they present misleading information regarding the side effects of clopidogrel.
openaire   +3 more sources

Human cyclic neutropenia transferred by allogeneic bone marrow grafting [PDF]

open access: bronze, 1982
RA Krance   +6 more
openalex   +1 more source

Cyclical Neutropenia [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1968
D I, Evans, A, Holzel
openaire   +2 more sources

Transient Neutropenia in a Patient Receiving Cimetidine

open access: bronze, 1977
M.H. Ufberg   +3 more
openalex   +1 more source

Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy [PDF]

open access: bronze, 1983
James B. Bussel   +6 more
openalex   +1 more source

Folate‐Associated DNA Methylation and Chemotherapy‐Induced Toxicities in Patients With Colorectal Cancer

open access: yesMolecular Nutrition &Food Research, EarlyView.
Over half of patients with colorectal cancer experience severe chemotherapy‐induced side effects. The B‐vitamin folate may play a role in these side effects, potentially by altering DNA methylation, a mechanism of gene regulation. Our comprehensive literature search identified studies investigating DNA methylation associated with folate status/intake ...
Nienke R. K. Zwart   +3 more
wiley   +1 more source

Benign ethnic neutropenia.

open access: yesBlood reviews, 2019
S. Atallah-Yunes, A. Ready, P. Newburger
semanticscholar   +1 more source

On the Mechanisms of Haemodialysis-induced Neutropenia: A Study with Five New and Re-used Membranes [PDF]

open access: green, 1988
Ch. Heierli   +4 more
openalex   +1 more source

Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy

open access: yesThe Journal of Pathology, EarlyView.
Abstract In recent years, targeted therapies have become the standard of care for refractory/relapsed mantle cell lymphoma (MCL). Although the mutational profile of MCL has been extensively studied, there is a lack of understanding of resistance mechanisms and genetic factors that impact the response to novel treatments.
Tamás László   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy